For now, RNF144 is involved in regulatory roles in numerous diseases, and exploring a criterion as a biomarker for diagnosing diseases, especially digestive and reproductive tumors, is worthy of our consideration, and the development of targeted biologics specific for RNF144 is a new direction for targeted therapy. This evidence concerns the gene RNF144A and reproductive system neoplasm.